Ciliopathy interacts with neonatal anesthesia to cause non-apoptotic caspase-mediated motor deficits

Insights

Ketamine anesthesia can impair motor skills in newborns with genetic ciliopathies. This neurotoxicity is linked to altered neuronal connections and can be reversed by inhibiting caspase activity, suggesting a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Genetics

Background:

  • Anesthesia may cause developmental neurotoxicity, but its interaction with genetic predispositions is unclear.
  • Children with congenital heart disease often have ciliary dysfunction and require neonatal anesthesia.

Purpose of the Study:

  • To investigate how genetic ciliopathy influences anesthesia-induced neurotoxicity.
  • To explore the role of caspase activation in ketamine-induced motor deficits.

Main Methods:

  • Neonatal mice with ciliopathy were exposed to ketamine.
  • Assessed motor skills, neocortical neuron apical spine density, and caspase activation.
  • Investigated the effect of caspase suppression on neurodevelopmental outcomes.

Main Results:

  • Ketamine exposure caused motor skill impairments in ciliopathic mice.
  • These deficits were associated with reduced apical spine density and altered spine dynamics.
  • Augmented non-apoptotic caspase activation was observed and linked to these changes.
  • Caspase suppression rescued spine density and motor deficits.

Conclusions:

  • Ciliopathy exacerbates ketamine-induced motor impairments.
  • Sublethal caspase signaling is crucial for spine formation and motor learning.
  • Caspase inhibition may reverse ketamine-induced neurodevelopmental deficits in vulnerable neonates.